Immunological applications of stem cells in type 1 diabetes.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Endocrine reviews

• Publication date

  2011-08-23

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1210/er.2011-0008PMID 21862682PMCID PMC3591677
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Supplementary Materials and Methods

  2013cited by this paper
• Sequences Human Induced Pluripotent Stem Cells Free of Vector and Transgene

  2012cited by this paper
• Human Induced Pluripotent Stem Cells Derived from Fetal Neural Stem Cells Successfully Undergo Directed Differentiation into Cartilage

  2011cited by this paper
• Stem cell-based therapies and immunomodulatory approaches in newly diagnosed type 1 diabetes.

  2011cited by this paper
• Generation of adult human induced pluripotent stem cells using nonviral minicircle DNA vectors

  2011cited by this paper
• Immunogenicity of induced pluripotent stem cells

  2011cited by this paper
• Immunogenicity of induced pluripotent stem cells.

  2011influential reference
• iPS Cells in Type 1 Diabetes Research and Treatment

  2011influential reference
• Induced pluripotent stem cells: a novel frontier in the study of human primary immunodeficiencies.

  2011cited by this paper
• Correction of hyperglycemia in type 1 diabetic models by transplantation of encapsulated insulin-producing cells derived from mouse embryo progenitor.

  2011cited by this paper
• Independence of exogenous insulin following immunoablation and stem cell reconstitution in newly diagnosed diabetes type I

  2011cited by this paper
• Immune regulatory cells in umbilical cord blood and their potential roles in transplantation tolerance.

  2011cited by this paper
• Mesenchymal stem cells express serine protease inhibitor to evade the host immune response.

  2011cited by this paper
• Induced pluripotent stem cells from individuals with recessive dystrophic epidermolysis bullosa.

  2011cited by this paper
• Allogeneic Hematopoietic Stem-Cell Transplantation for Sickle Cell Disease

  2011cited by this paper
• Network of WNT and other regulatory signaling cascades in pluripotent stem cells and cancer stem cells.

  2011cited by this paper
• Incomplete DNA methylation underlies a transcriptional memory of somatic cells in human iPS cells

  2011cited by this paper
• A low frequency of pancreatic islet insulin-expressing cells derived from cord blood stem cell allografts in humans

  2011influential reference
• Targeting the CXCR4–CXCL12 Axis Mobilizes Autologous Hematopoietic Stem Cells and Prolongs Islet Allograft Survival via Programmed Death Ligand 1

  2011cited by this paper
• Transplantation of mouse embryonic stem cells induces hematopoietic and tissue chimerism in rats

  2010cited by this paper
• Transient activation of c-MYC expression is critical for efficient platelet generation from human induced pluripotent stem cells

  2010cited by this paper
• Evaluation of 28 Human Embryonic Stem Cell Lines for Use as Unrelated Donors in Stem Cell Therapy: Implications of HLA and ABO Genotypes

  2010cited by this paper
• Discovery of a CXCR4 agonist pepducin that mobilizes bone marrow hematopoietic cells

  2010cited by this paper
• Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years’ experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases

  2010influential reference
• Comparison of efficiency of terminal differentiation of oligodendrocytes from induced pluripotent stem cells versus embryonic stem cells in vitro.

  2010cited by this paper
• Hemangioblastic Derivatives from Human Induced Pluripotent Stem Cells Exhibit Limited Expansion and Early Senescence

  2010cited by this paper
• Cord blood hematopoietic stem cell transplantation ∗

  2010influential reference
• Neuroscience in a virtual world

  2010cited by this paper
• Aggressive fibromatosis (desmoid tumor) is derived from mesenchymal progenitor cells.

  2010cited by this paper
• Robust Enhancement of Neural Differentiation from Human ES and iPS Cells Regardless of their Innate Difference in Differentiation Propensity

  2010cited by this paper
• Mesenchymal Stem Cells Overexpressing IFN-β Inhibit Breast Cancer Growth and Metastases through Stat3 Signaling in a Syngeneic Tumor Model

  2010cited by this paper
• Mesenchymal Stem Cells Protect Breast Cancer Cells through Regulatory T Cells: Role of Mesenchymal Stem Cell-Derived TGF-β

  2010cited by this paper
• Identification and classification of chromosomal aberrations in human induced pluripotent stem cells.

  2010cited by this paper
• Taming killer cells may halt diabetes progression

  2010cited by this paper
• Characteristics of the Early Immune Response Following Transplantation of Mouse ES Cell Derived Insulin-Producing Cell Clusters

  2010cited by this paper
• Human mesenchymal stem cells inhibit metastasis of a hepatocellular carcinoma model using the MHCC97‐H cell line

  2010cited by this paper
• Human Embryonic Stem Cell-extracts Inhibit the Differentiation and Function of Monocyte-derived Dendritic Cells

  2010cited by this paper
• Cancer/Testis antigen expression on mesenchymal stem cells isolated from different tissues.

  2010cited by this paper
• iPS cell aberrations

  2010cited by this paper
• Differentiation of Allogeneic Mesenchymal Stem Cells Induces Immunogenicity and Limits Their Long-Term Benefits for Myocardial Repair

  2010cited by this paper
• Human mesenchymal stem cells modulate cellular immune response to islet antigen glutamic acid decarboxylase in type 1 diabetes.

  2010cited by this paper
• Differences between Cellular and Molecular Profiles of Induced Pluripotent Stem Cells Generated from Mouse Embryonic Fibroblasts

  2010cited by this paper
• Congenic Mesenchymal Stem Cell Therapy Reverses Hyperglycemia in Experimental Type 1 Diabetes

  2010cited by this paper
• Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009

  2010cited by this paper
• Notch signaling: a novel regulating differentiation mechanism of human umbilical cord blood-derived mesenchymal stem cells into insulin-producing cells in vitro.

  2010cited by this paper
• Derivation of Induced Pluripotent Stem Cells from Human Peripheral Blood T Lymphocytes

  2010cited by this paper
• Regulation of somatic cell reprogramming through inducible mir-302 expression

  2010cited by this paper
• Tumorigenicity of pluripotent stem cells: biological insights from molecular imaging

  2010cited by this paper
• Overview of Very Small Embryonic‐Like Stem Cells (VSELs) and Methodology of Their Identification and Isolation by Flow Cytometric Methods

  2010cited by this paper
• Mesenchymal stem cells derived from human gingiva are capable of immunomodulatory functions and ameliorate inflammation-related tissue destruction in experimental colitis

  2010cited by this paper
• Genetics, pathogenesis and clinical interventions in type 1 diabetes

  2010cited by this paper
• Harnessing the pancreatic stem cell.

  2010cited by this paper
• High-Efficient Generation of Induced Pluripotent Stem Cells from Human Astrocytes

  2010cited by this paper
• Cord Blood Hematopoietic Cell Transplantation

  2010cited by this paper
• CD14+ monocytes promote the immunosuppressive effect of human umbilical cord matrix stem cells.

  2010cited by this paper
• Isolation and Characterization of Mesenchymal Stem Cells From the Sub-Amniotic Human Umbilical Cord Lining Membrane

  2010cited by this paper
• Immunological and regenerative properties of cord blood stem cells.

  2010cited by this paper
• Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells.

  2010cited by this paper
• Stem cell therapy for type 1 diabetes mellitus

  2010cited by this paper
• Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA.

  2010cited by this paper
• Mesenchymal Stem Cells Promote Mammosphere Formation and Decrease E-Cadherin in Normal and Malignant Breast Cells

  2010cited by this paper
• Long-Acting Insulin Analogs and the Risk of Diabetic Ketoacidosis in Children and Adolescents With Type 1 Diabetes

  2010cited by this paper
• Generation of mouse-induced pluripotent stem cells with plasmid vectors

  2010cited by this paper
• Mesenchymal stem cells derived from human gingiva are capable of immunomodulatory functions and ameliorate inflammation-related tissue destruction in experimental colitis. J. Immunol. 183: 7787-7798

  2010cited by this paper
• Memory in Induced Pluripotent Stem Cells: Reprogrammed Human Retinal‐Pigmented Epithelial Cells Show Tendency for Spontaneous Redifferentiation

  2010cited by this paper
• High dosage of Exendin-4 increased early insulin secretion in differentiated beta cells from mouse embryonic stem cells

  2010cited by this paper
• Human Bone Marrow Mesenchymal Stem Cells Display Anti-Cancer Activity in SCID Mice Bearing Disseminated Non-Hodgkin's Lymphoma Xenografts

  2010cited by this paper
• Potential role of mesenchymal stem cells (MSCs) in the breast tumour microenvironment: stimulation of epithelial to mesenchymal transition (EMT)

  2010cited by this paper
• Epigenetic Mechanisms Regulate MHC and Antigen Processing Molecules in Human Embryonic and Induced Pluripotent Stem Cells

  2010influential reference
• Induced pluripotent stem cells as a model for accelerated patient- and disease-specific drug discovery.

  2010cited by this paper
• Autologous Umbilical Cord Blood Transfusion in Very Young Children With Type 1 Diabetes

  2009cited by this paper
• Generation of induced pluripotent stem cells from human cord blood using OCT4 and SOX2.

  2009influential reference
• Mesenchymal stem cell-derived microvesicles protect against acute tubular injury.

  2009cited by this paper
• Generation of Pancreatic Hormone‐Expressing Islet‐Like Cell Aggregates from Murine Adipose Tissue‐Derived Stem Cells

  2009cited by this paper
• Oct4 and LIF/Stat3 additively induce Krüppel factors to sustain embryonic stem cell self-renewal.

  2009cited by this paper
• Mesenchymal stem cells protect NOD mice from diabetes by inducing regulatory T cells

  2009cited by this paper
• Human β-cell Precursors Mature Into Functional Insulin-producing Cells in an Immunoisolation Device: Implications for Diabetes Cell Therapies

  2009cited by this paper
• Interplay of Oct4 with Sox2 and Sox17: a molecular switch from stem cell pluripotency to specifying a cardiac fate

  2009cited by this paper
• Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders.

  2009cited by this paper
• Changes in gene expression and morphology of mouse embryonic stem cells on differentiation into insulin‐producing cells in vitro and in vivo

  2009cited by this paper
• CD34 is a Key Regulator of Hematopoietic Stem Cell Trafficking to Bone Marrow and Mast Cell Progenitor Trafficking in the Periphery

  2009cited by this paper
• Genetically transforming human mesenchymal stem cells to sarcomas

  2009cited by this paper
• Highly efficient differentiation of human ES cells and iPS cells into mature pancreatic insulin-producing cells

  2009cited by this paper
• Generation of induced pluripotent stem cells from human cord blood.

  2009cited by this paper
• The tumorigenicity of diploid and aneuploid human pluripotent stem cells

  2009cited by this paper
• Mesenchymal Stem Cells Derived from Human Gingiva Are Capable of Immunomodulatory Functions and Ameliorate Inflammation-Related Tissue Destruction in Experimental Colitis1

  2009cited by this paper
• Transcriptional Signature and Memory Retention of Human-Induced Pluripotent Stem Cells

  2009cited by this paper
• Analysis of Allogenicity of Mesenchymal Stem Cells in Engraftment and Wound Healing in Mice

  2009cited by this paper
• Generation of iPS cells using defined factors linked via the self-cleaving 2A sequences in a single open reading frame

  2009cited by this paper
• Human Cord Blood Stem Cell-Modulated Regulatory T Lymphocytes Reverse the Autoimmune-Caused Type 1 Diabetes in Nonobese Diabetic (NOD) Mice

  2009influential reference
• Stem cell therapy for type 1 diabetes mellitus: a review of recent clinical trials

  2009cited by this paper
• Deconstructing Stem Cell Tumorigenicity: A Roadmap to Safe Regenerative Medicine

  2009cited by this paper
• ES Cell Extract‐Induced Expression of Pluripotent Factors in Somatic Cells

  2009cited by this paper
• Generation of pluripotent stem cells from patients with type 1 diabetes

  2009influential reference
• Characterization of Dendritic Cells and Macrophages Generated by Directed Differentiation from Mouse Induced Pluripotent Stem Cells

  2009influential reference
• Immunomodulatory Function of Bone Marrow-Derived Mesenchymal Stem Cells in Experimental Autoimmune Type 1 Diabetes1

  2009influential reference
• Differentiation of human umbilical cord blood-derived mononuclear cells to endocrine pancreatic lineage.

  2009cited by this paper
• Effects of encapsulated rabbit mesenchymal stem cells on ex vivo expansion of human umbilical cord blood hematopoietic stem/progenitor cells.

  2009cited by this paper
• Autologous mesenchymal stem cells produce reverse remodelling in chronic ischaemic cardiomyopathy.

  2009cited by this paper
• Induced pluripotent stem cells generated without viral integration

  2009cited by this paper

• Stem Cell-Derived Beta-Cell Therapies: Encapsulation Advances and Immunological Hurdles in Diabetes Treatment

  2026cites this paper
• Insulin delivery modality and Ramadan fasting interruption, glycemic control, and fear of hypoglycemia in type 1 diabetes: a prospective, multicenter study from Saudi Arabia.

  2026cites this paper
• Potentials of bone marrow cells-derived from naïve or diabetic mice in autoimmune type 1 diabetes: immunomodulatory, anti-inflammatory, anti hyperglycemic, and antioxidative

  2024cites this paper
• Innovative Immunotherapies and Emerging Treatments in Type 1 Diabetes Management

  2024cites this paper
• Advances in alginate encapsulation of pancreatic islets for immunoprotection in type 1 diabetes

  2023cites this paper
• Efficiency of Bone Marrow-Derived Mesenchymal Stem Cells and Hesperetin in the Treatment of Streptozotocin-Induced Type 1 Diabetes in Wistar Rats

  2023cites this paper
• Stem Cell Therapy for the Management of Type 1 Diabetes: Advances and Perspectives.

  2023cites this paper
• Pancreatic transplant surgery and stem cell therapy: Finding the balance between therapeutic advances and ethical principles

  2022cites this paper
• Challenges with Cell-based Therapies for Type 1 Diabetes Mellitus

  2022cites this paper
• Differentiation of Alginate-Encapsulated Wharton Jelly-Derived Mesenchymal Stem Cells into Insulin Producing Cells

  2022cites this paper
• Combination therapy with human amniotic epithelial cells and hyaluronic acid promotes immune balance recovery in type 1 diabetic rats through local engraftment

  2022cites this paper
• Benefits and Hurdles of Pancreatic β-Cell Replacement

  2022cites this paper
• Managing Type 1 Diabetes from Gynecological Waste: Trash to Treasure.

  2022cites this paper
• Pharmacologically Enhanced Regulatory Hematopoietic Stem Cells Revert Experimental Autoimmune Diabetes and Mitigate Other Autoimmune Disorders

  2022cites this paper
• Hematopoietic Stem Cells in Type 1 Diabetes

  2021cites this paper
• Analysis of Key Distinct Biological Characteristics of Human Placenta-Derived Mesenchymal Stromal Cells and Individual Heterogeneity Attributing to Donors

  2021cites this paper
• Syngeneic bone marrow transplantation in combination with PI3K inhibitor reversed hyperglycemia in later-stage streptozotocin-induced diabetes

  2021cites this paper
• Circulating Hematopoietic (HSC) and Very-Small Embryonic like (VSEL) Stem Cells in Newly Diagnosed Childhood Diabetes type 1 – Novel Parameters of Beta Cell Destruction/Regeneration Balance and Possible Prognostic Factors of Future Disease Course

  2021cites this paper
• Role of stem cell therapy in diabetic nephropathy in rats: biochemical, histological and immunohistochemical study

  2021cites this paper
• Allogenic Adipose Tissue-Derived Stromal/Stem Cells and Vitamin D Supplementation in Patients With Recent-Onset Type 1 Diabetes Mellitus: A 3-Month Follow-Up Pilot Study

  2020cites this paper
• Progress toward islet transplantation tolerance

  2020cites this paper
• Efficacy and Safety of Stem Cell Therapy for T1DM: An Updated Systematic Review and Meta-Analysis

  2020cites this paper
• Anti-Inflammatory Effect of Mallotus Philippinensis Bark Extracts in a Mouse Atopic Dermatitis Model

  2020cites this paper
• Concise review: current trends on applications of stem cells in diabetic nephropathy

  2020cites this paper
• Tissue engineering: current status and future perspectives

  2020cites this paper
• Cell-based immunomodulatory therapy approaches for type 1 diabetes mellitus.

  2019cites this paper
• Identification and characterization of cartilage progenitor cells by single cell sorting and cloning

  2019cites this paper
• Investigating the route of administration and efficacy of adipose tissue-derived mesenchymal stem cells and conditioned medium in type 1 diabetic mice

  2019cites this paper
• Harnessing CXCL12 signaling to protect and preserve functional &bgr;‐cell mass and for cell replacement in type 1 diabetes

  2019cites this paper
• Co-transplantation of Human Fetal Mesenchymal and Hematopoietic Stem Cells in Type 1 Diabetic Mice Model

  2019cites this paper
• Bone Marrow Mesenchymal Stem Cells as a New Therapeutic Approach for Diabetes Mellitus

  2019cites this paper
• Diabetes Mellitus

  2019cites this paper
• Direct comparison of the abilities of bone marrow mesenchymal versus hematopoietic stem cells to reverse hyperglycemia in diabetic NOD.SCID mice

  2018cites this paper
• Current and Future Approaches to Stem Cell Treatment of Type I Diabetes

  2018influential citation
• Polytherapy with Reserpine and Glucagon-like Peptide-1 (GLP-1) Improves the Symptoms in Streptozotocin-Induced Type-1 Diabetic Mice by Reducing Inflammation and Inducting Beta Cell Regeneration

  2018cites this paper
• Prostaglandin E2 Stimulates the Expansion of Regulatory Hematopoietic Stem and Progenitor Cells in Type 1 Diabetes

  2018cites this paper
• Comprehensive assessment of T‐cell repertoire following autologous hematopoietic stem cell transplantation for treatment of type 1 diabetes using high‐throughput sequencing

  2018cites this paper
• Stem Cell Therapy and Type 1 Diabetes Mellitus: Treatment Strategies and Future Perspectives.

  2018cites this paper
• β-Catenin Accumulation is Associated with Increased Expression of Nanog Protein and Predicts Maintenance of MSC Self-Renewal

  2017cites this paper
• Concise Review: Perspectives and Clinical Implications of Bone Marrow and Circulating Stem Cell Defects in Diabetes

  2017cites this paper
• New Advances in Stem Cell Therapy for Diabetes Mellitus

  2017cites this paper
• Mesenchymal stem cells and differentiated insulin producing cells are new horizons for pancreatic regeneration in type I diabetes mellitus.

  2017cites this paper
• Stem Cell Therapy for Type-1 Diabetes Mellitus

  2017cites this paper
• PD-L1 genetic overexpression or pharmacological restoration in hematopoietic stem and progenitor cells reverses autoimmune diabetes

  2017cites this paper
• Comparison of human mesenchymal stromal cells from four neonatal tissues: Amniotic membrane, chorionic membrane, placental decidua and umbilical cord.

  2017cites this paper
• Clinical benefits of autologous haematopoietic stem cell transplantation in type 1 diabetes patients.

  2017cites this paper
• Diabetes mellitus as a poor mobilizer condition.

  2017cites this paper
• Bone regeneration in the stem cell era: safe play for the patient?

  2017cites this paper
• Adipose Stem Cell Therapy for Chronic Pancreatitis.

  2017cites this paper
• Expansion strategies for human mesenchymal stromal cells culture under xeno‐free conditions

  2017cites this paper
• Targeting Immunity in End-Stage Renal Disease

  2017cites this paper
• Considerations on the harvesting site and donor derivation for mesenchymal stem cells-based strategies for diabetes.

  2017cites this paper
• Immunoevasion rather than intrinsic oncogenicity may confer MSCs from non-obese diabetic mice the ability to generate neural tumors

  2017cites this paper
• The origin, in vitro differentiation, and stemness specificity of progenitor cells.

  2017cites this paper
• Durable Control of Autoimmune Diabetes in Mice Achieved by Intraperitoneal Transplantation of “Neo‐Islets,” Three‐Dimensional Aggregates of Allogeneic Islet and “Mesenchymal Stem Cells”

  2017cites this paper
• Immunotherapy for type 1 diabetes

  2017cites this paper
• Microvascular Complications in Type 1 Diabetes: A Comparative Analysis of Patients Treated with Autologous Nonmyeloablative Hematopoietic Stem-Cell Transplantation and Conventional Medical Therapy

  2017cites this paper
• Cell-based therapies for experimental diabetic nephropathy: a systematic review and meta-analysis.

  2016cites this paper
• Evaluation of the clinical efficacy of stem cell transplantation in patients with type 1 diabetes mellitus

  2016influential citation
• Standards , Policies , Protocols , and Regulations for Cell-Based Therapies Residual b-Cell Function Predicts Clinical Response After Autologous Hematopoietic Stem Cell Transplantation

  2016cites this paper
• Mesenchymal stem cells moderate immune response of type 1 diabetes

  2016cites this paper
• Stem cell therapy emerging as the key player in treating type 1 diabetes mellitus.

  2016cites this paper
• Status of stem cells in diabetic nephropathy: predictive and preventive potentials

  2016cites this paper
• Transcriptional profiling reveals intrinsic mRNA alterations in multipotent mesenchymal stromal cells isolated from bone marrow of newly-diagnosed type 1 diabetes patients

  2016cites this paper
• Can Diabetes Heal?- From Observations to Perspectives.

  2016cites this paper
• CXCR4 antagonism overcomes diabetic stem cell mobilopathy.

  2016cites this paper
• The use of hematopoietic stem cells in autoimmune diseases.

  2016cites this paper
• Residual β‐Cell Function Predicts Clinical Response After Autologous Hematopoietic Stem Cell Transplantation

  2016cites this paper
• Concise Review: Cell‐Based Therapies and Other Non‐Traditional Approaches for Type 1 Diabetes

  2016cites this paper
• Gastrointestinal Tract and Endocrine System

  2016cites this paper
• Humanized Mice as Preclinical Models in Transplantation.

  2016cites this paper
• Potential Immune Modulatory Action of Mesenchymal Stem Cell- Derived Extracellular Vesicles in Type 1 Diabetes

  2015influential citation
• Human iPS Cell-Derived Insulin Producing Cells Form Vascularized Organoids under the Kidney Capsules of Diabetic Mice

  2015cites this paper
• The Co-Transplantation of Bone Marrow Derived Mesenchymal Stem Cells Reduced Inflammation in Intramuscular Islet Transplantation

  2015cites this paper
• Modern clinical management helps reducing the impact of type 1 diabetes in children.

  2015cites this paper
• Applicability of Adipose-Derived Stem Cells in Type 1 Diabetes Mellitus

  2015cites this paper
• An economic analysis of autologous hematopoietic stem cell transplantation (AHSCT) in the treatment of new onset type 1 diabetes

  2015cites this paper
• Clinical efficacy of autologous stem cell transplantation for the treatment of patients with type 2 diabetes mellitus: a meta-analysis.

  2015cites this paper
• Mesenchymal Stem Cells: Rising Concerns over Their Application in Treatment of Type One Diabetes Mellitus

  2015cites this paper
• A Combination of Human Embryonic Stem Cell-Derived Pancreatic Endoderm Transplant with LDHA-Repressing miRNA Can Attenuate High-Fat Diet Induced Type II Diabetes in Mice

  2015cites this paper
• Metabolic and Pancreatic Effects of Bone Marrow Mesenchymal Stem Cells Transplantation in Mice Fed High-Fat Diet

  2015cites this paper
• Umbilical Cord Mesenchymal Stromal Cell With Autologous Bone Marrow Cell Transplantation in Established Type 1 Diabetes: A Pilot Randomized Controlled Open-Label Clinical Study to Assess Safety and Impact on Insulin Secretion

  2015cites this paper
• Type 1 diabetes and T regulatory cells.

  2015cites this paper
• Re-engineering islet cell transplantation.

  2015cites this paper
• Co-transplantation of autologous MSCs delays islet allograft rejection and generates a local immunoprivileged site

  2015cites this paper
• Explaining the increased mortality in type 1 diabetes.

  2015cites this paper
• Cinnamtannin B-1 Promotes Migration of Mesenchymal Stem Cells and Accelerates Wound Healing in Mice

  2015cites this paper
• Undifferentiated Wharton's Jelly Mesenchymal Stem Cell Transplantation Induces Insulin-Producing Cell Differentiation and Suppression of T-Cell-Mediated Autoimmunity in Nonobese Diabetic Mice

  2015cites this paper
• The rise, fall, and resurgence of immunotherapy in type 1 diabetes.

  2015cites this paper
• Two Distinct Mechanisms Mediate the Involvement of Bone Marrow Cells in Islet Remodeling: Neogenesis of Insulin-Producing Cells and Support of Islet Recovery

  2015cites this paper
• Predictive factors for prolonged remission after autologous hematopoietic stem cell transplantation in young patients with type 1 diabetes mellitus.

  2015cites this paper
• Immunogenicity of β-cells for autologous transplantation in type 1 diabetes.

  2015cites this paper
• odern clinical management helps reducing the impact of type 1 iabetes in children

  2015cites this paper
• Population balance modelling of stem cell culture in 3D suspension bioreactors

  2015cites this paper
• Transplantation de cellules souches autologues dans le diabète de type 1 récent : des résultats mitigés

  2015cites this paper
• Novel therapies for T1D on the horizon.

  2015cites this paper
• Transplantation of Insulin-Producing Cells Differentiated from Human Periosteum-Derived Progenitor Cells Ameliorate Hyperglycemia in Diabetic Mice

  2014cites this paper
• Long‐term Outcomes after Islet Transplantation

  2014cites this paper
• Pluripotent Stem Cells as a Potential Tool for Disease Modelling and Cell Therapy in Diabetes

  2014cites this paper
• Human mesenchymal stem cell-derived microvesicles modulate T cell response to islet antigen glutamic acid decarboxylase in patients with type 1 diabetes

  2014cites this paper